ADVANZ
LIVE

Serial Number

97671247

Owner

MERCURY PHARMA GROUP LIMITED

Attorney

Caroline Duncan

Filing Date

Nov 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ADVANZ Trademark

Serial Number: 97671247

ADVANZ is a trademark filed by MERCURY PHARMA GROUP LIMITED on November 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

MERCURY PHARMA GROUP LIMITED (11 trademarks)

London EC4N7BL , GB

Entity Type: 03

Trademark Details

Filing Date

November 10, 2022

Registration Date

Not Registered

Published for Opposition

May 14, 2024

Goods & Services

A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations

Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 9, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 8, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 8, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 8, 2026 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 5, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 5, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 5, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 9, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 9, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 9, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 9, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 9, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
EXPARTE APPEAL TERMINATED
Apr 9, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2024 CRFA
ASSIGNED TO LIE
Mar 12, 2024 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 24, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Oct 24, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 24, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Oct 24, 2023 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 27, 2023 GNFN
FINAL REFUSAL E-MAILED
Sep 27, 2023 GNFR
FINAL REFUSAL WRITTEN
Sep 27, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 16, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 16, 2023 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 16, 2023 GPRN
PRIORITY ACTION E-MAILED
Feb 16, 2023 GPRA
PRIORITY ACTION WRITTEN
Feb 16, 2023 CPRA
EXAMINER'S AMENDMENT ENTERED
Jan 19, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 19, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 19, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 19, 2023 CNEA
ASSIGNED TO EXAMINER
Jan 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2022 NWOS
NEW APPLICATION ENTERED
Nov 14, 2022 NWAP